Advances in IBD

Advances in IBD

Source:

Mahadevan U. “Hot Topics in Pregnancy and IBD: The PIANO Study.” Presented at: Advances in Inflammatory Bowel Diseases. Dec. 9-12, 2020.

Disclosures: Mahadevan reports consulting for AbbVie, Janssen, Pfizer and Takeda and receiving a research grant from Pfizer.
December 19, 2020
1 min watch
Save

VIDEO: IBD therapies not linked with adverse pregnancy outcomes

Source:

Mahadevan U. “Hot Topics in Pregnancy and IBD: The PIANO Study.” Presented at: Advances in Inflammatory Bowel Diseases. Dec. 9-12, 2020.

Disclosures: Mahadevan reports consulting for AbbVie, Janssen, Pfizer and Takeda and receiving a research grant from Pfizer.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this exclusive video, Uma Mahadevan, MD, from the University of California, San Francisco, discusses the results of the PIANIO Study, which explores outcomes of pregnant women with inflammatory bowel disease and their children.

She said they found no association between biologic, thiopurine or combination therapy and adverse outcomes at birth or within the first year of life. Additionally, she said physicians should continue providing IBD medication throughout pregnancy.